Correction to: Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial (Neuropsychopharmacology, (2022), 47, 8, (1574-1581), 10.1038/s41386-022-01266-9)

Chadi G. Abdallah; John D. Roache; Ralitza Gueorguieva; Lynnette A. Averill; Stacey Young-McCaughan; Paulo R. Shiroma; Prerana Purohit; Antoinette Brundige; William Murff; Kyung Heup Ahn; Mohamed A. Sherif; Eric J. Baltutis; Mohini Ranganathan; Deepak D’Souza; Brenda Martini; Steven M. Southwick; Ismene L. Petrakis; Rebecca R. Burson; Kevin B. Guthmiller; Argelio L. López-Roca; Karl A. Lautenschlager; John P. McCallin; Matthew B. Hoch; Alexandar Timchenko; Sergio E. Souza; Charles E. Bryant; Jim Mintz; Brett T. Litz; Douglas E Williamson; Terence M. Keane; Alan L Peterson; John H. Krystal

doi:10.1038/s41386-022-01339-9

Correction to: Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial (Neuropsychopharmacology, (2022), 47, 8, (1574-1581), 10.1038/s41386-022-01266-9)

Chadi G. Abdallah
, John D. Roache
, Ralitza Gueorguieva
, Lynnette A. Averill
, Stacey Young-McCaughan
, Paulo R. Shiroma
, Prerana Purohit
, Antoinette Brundige
, William Murff
, Kyung Heup Ahn
, Mohamed A. Sherif
, Eric J. Baltutis
, Mohini Ranganathan
, Deepak D’Souza
, Brenda Martini
, Steven M. Southwick
, Ismene L. Petrakis
, Rebecca R. Burson
, Kevin B. Guthmiller
, Argelio L. López-Roca

Karl A. Lautenschlager, John P. McCallin, Matthew B. Hoch, Alexandar Timchenko, Sergio E. Souza, Charles E. Bryant, Jim Mintz, Brett T. Litz, Douglas E Williamson, Terence M. Keane, Alan L Peterson, John H. Krystal

Department of Psychiatry & Behavioral Sciences

Producción científica: Comment/debate › revisión exhaustiva

1 Cita (Scopus)

Resumen

In Table 1 of this article, the values in the row headed ‘CAPS-5’ have been corrected. They now read as shown below. The original article has been corrected.

Idioma original	English (US)
Páginas (desde-hasta)	1583-1584
Número de páginas	2
Publicación	Neuropsychopharmacology
Volumen	47
N.º	8
DOI	https://doi.org/10.1038/s41386-022-01339-9
Estado	Published - jul 2022

ASJC Scopus subject areas

Pharmacology
Psychiatry and Mental health

Acceder al documento

10.1038/s41386-022-01339-9

Otros archivos y enlaces

Huella

Profundice en los temas de investigación de 'Correction to: Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial (Neuropsychopharmacology, (2022), 47, 8, (1574-1581), 10.1038/s41386-022-01266-9)'. En conjunto forman una huella única.

Citar esto

Abdallah, C. G., Roache, J. D., Gueorguieva, R., Averill, L. A., Young-McCaughan, S., Shiroma, P. R., Purohit, P., Brundige, A., Murff, W., Ahn, K. H., Sherif, M. A., Baltutis, E. J., Ranganathan, M., D’Souza, D., Martini, B., Southwick, S. M., Petrakis, I. L., Burson, R. R., Guthmiller, K. B., ... Krystal, J. H. (2022). Correction to: Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial (Neuropsychopharmacology, (2022), 47, 8, (1574-1581), 10.1038/s41386-022-01266-9). Neuropsychopharmacology, 47(8), 1583-1584. https://doi.org/10.1038/s41386-022-01339-9

Correction to: Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial (Neuropsychopharmacology, (2022), 47, 8, (1574-1581), 10.1038/s41386-022-01266-9). / Abdallah, Chadi G.; Roache, John D.; Gueorguieva, Ralitza et al.
En: Neuropsychopharmacology, Vol. 47, N.º 8, 07.2022, p. 1583-1584.

Producción científica: Comment/debate › revisión exhaustiva

Abdallah, CG, Roache, JD, Gueorguieva, R, Averill, LA, Young-McCaughan, S, Shiroma, PR, Purohit, P, Brundige, A, Murff, W, Ahn, KH, Sherif, MA, Baltutis, EJ, Ranganathan, M, D’Souza, D, Martini, B, Southwick, SM, Petrakis, IL, Burson, RR, Guthmiller, KB, López-Roca, AL, Lautenschlager, KA, McCallin, JP, Hoch, MB, Timchenko, A, Souza, SE, Bryant, CE, Mintz, J, Litz, BT, Williamson, DE, Keane, TM, Peterson, AL & Krystal, JH 2022, 'Correction to: Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial (Neuropsychopharmacology, (2022), 47, 8, (1574-1581), 10.1038/s41386-022-01266-9)', Neuropsychopharmacology, vol. 47, n.º 8, pp. 1583-1584. https://doi.org/10.1038/s41386-022-01339-9

Abdallah CG, Roache JD, Gueorguieva R, Averill LA, Young-McCaughan S, Shiroma PR et al. Correction to: Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial (Neuropsychopharmacology, (2022), 47, 8, (1574-1581), 10.1038/s41386-022-01266-9). Neuropsychopharmacology. 2022 jul;47(8):1583-1584. doi: 10.1038/s41386-022-01339-9

Abdallah, Chadi G. ; Roache, John D. ; Gueorguieva, Ralitza et al. / Correction to : Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial (Neuropsychopharmacology, (2022), 47, 8, (1574-1581), 10.1038/s41386-022-01266-9). En: Neuropsychopharmacology. 2022 ; Vol. 47, N.º 8. pp. 1583-1584.

@article{72a15c57e7664d4ba0c57c9ec4538e28,

title = "Correction to: Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial (Neuropsychopharmacology, (2022), 47, 8, (1574-1581), 10.1038/s41386-022-01266-9)",

abstract = "In Table 1 of this article, the values in the row headed {\textquoteleft}CAPS-5{\textquoteright} have been corrected. They now read as shown below. The original article has been corrected.",

author = "Abdallah, \{Chadi G.\} and Roache, \{John D.\} and Ralitza Gueorguieva and Averill, \{Lynnette A.\} and Stacey Young-McCaughan and Shiroma, \{Paulo R.\} and Prerana Purohit and Antoinette Brundige and William Murff and Ahn, \{Kyung Heup\} and Sherif, \{Mohamed A.\} and Baltutis, \{Eric J.\} and Mohini Ranganathan and Deepak D{\textquoteright}Souza and Brenda Martini and Southwick, \{Steven M.\} and Petrakis, \{Ismene L.\} and Burson, \{Rebecca R.\} and Guthmiller, \{Kevin B.\} and L{\'o}pez-Roca, \{Argelio L.\} and Lautenschlager, \{Karl A.\} and McCallin, \{John P.\} and Hoch, \{Matthew B.\} and Alexandar Timchenko and Souza, \{Sergio E.\} and Bryant, \{Charles E.\} and Jim Mintz and Litz, \{Brett T.\} and Williamson, \{Douglas E\} and Keane, \{Terence M.\} and Peterson, \{Alan L\} and Krystal, \{John H.\}",

note = "Publisher Copyright: {\textcopyright} 2022, This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.",

year = "2022",

month = jul,

doi = "10.1038/s41386-022-01339-9",

language = "English (US)",

volume = "47",

pages = "1583--1584",

journal = "Neuropsychopharmacology",

issn = "0893-133X",

publisher = "Springer Nature",

number = "8",

}

TY - JOUR

T1 - Correction to

T2 - Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial (Neuropsychopharmacology, (2022), 47, 8, (1574-1581), 10.1038/s41386-022-01266-9)

AU - Abdallah, Chadi G.

AU - Roache, John D.

AU - Gueorguieva, Ralitza

AU - Averill, Lynnette A.

AU - Young-McCaughan, Stacey

AU - Shiroma, Paulo R.

AU - Purohit, Prerana

AU - Brundige, Antoinette

AU - Murff, William

AU - Ahn, Kyung Heup

AU - Sherif, Mohamed A.

AU - Baltutis, Eric J.

AU - Ranganathan, Mohini

AU - D’Souza, Deepak

AU - Martini, Brenda

AU - Southwick, Steven M.

AU - Petrakis, Ismene L.

AU - Burson, Rebecca R.

AU - Guthmiller, Kevin B.

AU - López-Roca, Argelio L.

AU - Lautenschlager, Karl A.

AU - McCallin, John P.

AU - Hoch, Matthew B.

AU - Timchenko, Alexandar

AU - Souza, Sergio E.

AU - Bryant, Charles E.

AU - Mintz, Jim

AU - Litz, Brett T.

AU - Williamson, Douglas E

AU - Keane, Terence M.

AU - Peterson, Alan L

AU - Krystal, John H.

PY - 2022/7

Y1 - 2022/7

N2 - In Table 1 of this article, the values in the row headed ‘CAPS-5’ have been corrected. They now read as shown below. The original article has been corrected.

AB - In Table 1 of this article, the values in the row headed ‘CAPS-5’ have been corrected. They now read as shown below. The original article has been corrected.

UR - https://www.scopus.com/pages/publications/85129902502

UR - https://www.scopus.com/pages/publications/85129902502#tab=citedBy

U2 - 10.1038/s41386-022-01339-9

DO - 10.1038/s41386-022-01339-9

M3 - Comment/debate

C2 - 35545665

AN - SCOPUS:85129902502

SN - 0893-133X

VL - 47

SP - 1583

EP - 1584

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

IS - 8

ER -